nivolumab,rigosertib
onconova therapeutics,SymBio pharmaceuticals,Knight Therapeutics,bms
['rigoser', 'onconova therapeutics']
onconova therapeutics therapeutics announces updated data from investigator-sponsored phase 1/2a trial evaluating rigosertib in c 